Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

C100

2.66 SEK19/11 17:25
Less than 1K followers

C100

Spotlight Stock Market

Software

Technology

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
-16.35 %
-29.63 %
-35.90 %
-50.74 %
-63.31 %
-63.06 %
-96.78 %
-
-99.28 %

C100 is an investment company. The company is an owner and manager of a portfolio of growth companies around the global market, where the investment is mainly found in the technology and life science sectors. The vision is to create long-term returns and to drive business development within each investment. The company is headquartered in Stockholm.

Read more
Market cap
14.63M SEK
Turnover
-
Revenue
210K
EBIT %
-1,852.38 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
30/11
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release2026-10-05 23:09

C100 AB (publ) slutför fusion med dotterbolag

C100
Press release2026-09-09 20:36

Flaggningsmeddelande i C100 AB (publ)

C100
Regulatory press release2026-09-08 08:40

Flaggningsmeddelande i C100 AB (publ)

C100

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
Followings and notifications on followed companies
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release2026-09-08 08:30

C100 AB (publ) informerar om slutgiltigt utfall av Hunter Capital AB (publ):s offentliga kontanta budpliktserbjudande

C100
Regulatory press release2026-08-31 21:00

C100 publicerar delårsrapport april - juni 2026

C100
Regulatory press release2026-08-23 20:00

Uttalande från styrelsen i C100 AB (publ) med anledning av budpliktserbjudande från Hunter Capital AB (publ)

C100
Press release2026-08-10 08:30

C100 AB (publ) informerar om offentliggörandet av erbjudandehandling avseende Hunter Capital AB (publ):s offentliga kontanta budpliktserbjudande

C100
Press release2026-07-31 08:50

C100 AB (publ) kommenterar rättat budpliktsbud från Hunter Capital AB (publ)

C100
Press release2026-07-29 12:20

C100 AB (publ) kommenterar budpliktsbud från Hunter Capital AB (publ)

C100
Press release2026-07-13 07:00

C100 AB (publ) offentliggör tidsplan för sammanläggning av aktier

C100
Press release2026-07-06 12:40

C100 AB (publ): C100:s dotterbolag Hunter Capital Dry Eye IPR erhåller enhetligt europeiskt patentskydd i 18 EU-länder

C100
Press release2026-07-06 11:25

C100 AB (publ): C100:s portföljbolag Hunter Capital RTO 1 rapporterar viktiga framsteg i den planerade transaktionen med ResoTher Pharma

C100
Press release2026-07-02 11:05

C100 AB (publ): Information om passerad budpliktsgräns för Hunter Capital AB (publ)

C100
Press release2026-07-02 09:35

C100 AB (publ): Registrering av tidigare aviserad kvittningsemission hos Bolagsverket samt flaggningsmeddelande

C100
Press release2026-06-30 18:00

C100 AB (publ) genomför fusion med dotterbolag

C100
Press release2026-06-26 16:00

Kommuniké från årsstämma i C100 AB (publ)

C100
Press release2026-06-09 21:35

C100 AB (publ): C100 publicerar beslutsunderlag inför den ordinarie bolagsstämman

C100
Press release2026-05-28 08:00

Kallelse till årsstämma i C100 AB (publ)

C100
Regulatory press release2026-05-25 08:50

C100 AB (publ) ingår villkorat avtal om förvärv av bolag med patentportfölj från Hunter Capital AB (publ)

C100
Regulatory press release2026-05-15 17:00

C100 publicerar delårsrapport januari - mars 2026

C100